News

Public · Published

TD Cowen maintains Exelixis at Buy, raises price target to $76 from $55

TD Cowen maintained a Buy rating on Exelixis and raised its price target to $76 from $55, a 38.2% increase. The new target implies 14.8% upside from the October 29 close of $66.20.

Published:

Updated:

What happened

TD Cowen maintained a Buy rating on Exelixis and raised its price target to $76 from $55, a 38.2% increase. The new target implies 14.8% upside from the October 29 close of $66.20.

Confirmed

Global impact / market context

A higher price target signals an analyst expects more share price gain ahead. For Exelixis holders, it supports confidence in near-term performance, but a target is an opinion, not a guarantee, and other analysts listed lower targets.

Analyst inference

Five other recent analyst notes on Exelixis carried targets from $54 to $65, below TD Cowen's $76. That gap shows divided views on the company's outlook, so investors may see the upgrade as a more bullish outlier rather than consensus.

Analyst inference

What to watch

  1. Watch whether other analysts change their Exelixis ratings or price targets after TD Cowen's move, since the five most recent notes ranged from $54 to $65. Confirmed
  2. Compare TD Cowen's $76 target with the October 29 close of $66.20 to judge how much further upside the analyst now expects from the stock. Proposed
  3. Track whether Exelixis shares move toward the $76 target, which would suggest investors accept TD Cowen's more bullish view over lower peer targets. Analyst inference

Evidence

  • Original source link unavailable